Immunotherapy revolutionizes cancer therapeutics but shows limited efficacy in hormone receptor-positive (HR⁺)/human epidermal growth factor receptor 2-negative (HER2^-) breast cancer. By leveraging large-scale multi-omics and single-cell RNA sequencing (scRNA-seq), we character …